| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 3,222 | 1,798 | 4,121 | 5,681 |
| Depreciation and amortization | 2,169 | 2,145 | 2,195 | 3,284 |
| Deferred income taxes | -36 | 2,533 | -48 | -32 |
| Reserve for uncertain tax positions | -56 | 71 | -46 | 149 |
| Loss on disposal of property and equipment | NaN | -61 | NaN | NaN |
| Non-cash share-based compensation expense | 1,608 | 1,909 | 925 | 478 |
| Change in fair value of contingent consideration | 0 | 10 | 49 | 82 |
| Loss on extinguishment of debt | 0 | 0 | 0 | -67 |
| Amortization of debt issuance costs | 27 | 27 | 28 | 47 |
| Trade accounts receivable | -275 | -1,641 | 332 | 1,362 |
| Prepaid expenses and other current and noncurrent assets | 1,627 | -1,045 | -1,793 | 2,814 |
| Deferred contract costs, net | 625 | 577 | 348 | 11 |
| Operating lease assets and liabilities, net | 30 | 1 | -13 | 53 |
| Accounts payable | 942 | 104 | -91 | 157 |
| Accrued expenses, wages and bonuses | -889 | -476 | 1,478 | 668 |
| Income taxes receivable and payable | 1,265 | -1,437 | 1,897 | -651 |
| Deferred revenue | 935 | -1,674 | 2,130 | -183 |
| Net cash provided by operating activities | 7,180 | 7,179 | 13,764 | 5,507 |
| Capital expenditures | 1,834 | 1,121 | 3,589 | 5,996 |
| Acquisitions, net of cash acquired | NaN | 0 | 0 | NaN |
| Proceeds from the sale of property and equipment | NaN | 0 | NaN | NaN |
| Net cash used in investing activities | -1,834 | -1,121 | -3,589 | -5,996 |
| Payments on notes payable | 0 | 0 | 0 | 47,681 |
| Borrowings on notes payable | 1,030 | 1,031 | 947 | 29,446 |
| Borrowings on revolving loan | 2,500 | 4,000 | 5,000 | 28,000 |
| Payments on revolving loan | 2,500 | 4,000 | 5,000 | 28,003 |
| Payment of debt issuance costs | 0 | -1 | 0 | 135 |
| Payments on finance lease obligations | 3 | 2 | 2 | 5 |
| Proceeds from the exercise of share-based awards | 139 | 0 | 0 | 132 |
| Payment of payroll tax withholdings on share-based awards exercised | NaN | 407 | 0 | 0 |
| Payment of acquisition contingent consideration | 484 | 0 | 236 | 280 |
| Repurchase of shares for treasury | 1,935 | 1 | 9,269 | 10,910 |
| Payment of dividends on common stock | 3,625 | 2,698 | 2,776 | 5,504 |
| Net cash used in financing activities | -6,938 | -4,138 | -13,230 | 1,530 |
| Effect of exchange rate changes on cash | NaN | 0 | NaN | NaN |
| Change in cash and cash equivalents | -1,592 | 1,920 | -3,055 | 1,041 |
| Cash and cash equivalents at beginning of period | 4,139 | 2,219 | 4,233 | NaN |
| Cash and cash equivalents at end of period | 2,547 | 4,139 | 2,219 | NaN |
NATIONAL RESEARCH CORP (NRC)
NATIONAL RESEARCH CORP (NRC)